Pages that link to "Q37686847"
Jump to navigation
Jump to search
The following pages link to O6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (Q37686847):
Displaying 38 items.
- Isolation and structural characterization of a cDNA clone encoding the human DNA repair protein for O6-alkylguanine (Q24336908) (← links)
- Preclinical Childhood Sarcoma Models: Drug Efficacy Biomarker Identification and Validation (Q26784048) (← links)
- Active and alkylated human AGT structures: a novel zinc site, inhibitor and extrahelical base binding (Q27622042) (← links)
- Reduction of BCNU toxicity to lung cells by high-level expression of O(6)-methylguanine-DNA methyltransferase (Q32128152) (← links)
- MGMT: its role in cancer aetiology and cancer therapeutics (Q34310201) (← links)
- The role of surrogate markers in the clinical development of antiretroviral therapy: a model for early evaluation of targeted cancer drugs (Q35740281) (← links)
- Drug resistance in myeloma: mechanisms and approaches to circumvention (Q36097679) (← links)
- Cytoplasmic sequestration of an O6-methylguanine-DNA methyltransferase enhancer binding protein in DNA repair-deficient human cells (Q36130099) (← links)
- New delivery approaches for pediatric brain tumors (Q36272990) (← links)
- Modulation of antitumor alkylating agents (AA) (Q36546730) (← links)
- MGMT: a personal perspective (Q36812588) (← links)
- Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide (Q38129776) (← links)
- An O6-methylguanine-DNA methyltransferase-like protein from Thermus thermophilus interacts with a nucleotide excision repair protein (Q38290938) (← links)
- Affinity purification and characterization of human O6-alkylguanine-DNA alkyltransferase complexed with BCNU-treated, synthetic oligonucleotide (Q38343790) (← links)
- The sensitivity of MCF10A breast epithelial cells to alkylating drugs is enhanced by the inhibition of O6-methylguanine-DNA methyltransferase transcription with a synthetic double strand DNA oligonucleotide. (Q38363836) (← links)
- Impact of O6-methylguanine-DNA methyltransferase expression on the drug resistance of clear cell renal cell carcinoma (Q38851881) (← links)
- Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines (Q38906083) (← links)
- Quantification of DNA interstrand crosslinks induced by ACNU in NIH/3T3 and L1210 cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry (Q39027144) (← links)
- Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro (Q39993380) (← links)
- O 6 -Alkylguanine-DNA Alkyltransferase: A Target for the Modulation of Drug Resistance (Q40464109) (← links)
- Cellular resistance to cancer chemotherapy. (Q40596146) (← links)
- Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity. (Q40775397) (← links)
- Antitumor efficacy of SarCNU in a human glioma xenograft model expressing both MGMT and extraneuronal monoamine transporter (Q40806753) (← links)
- Amplification of the DNA repair gene O6-methylguanine-DNA methyltransferase associated with resistance to alkylating drugs in a mammalian cell line (Q41109937) (← links)
- Development of a Novel Fluorescence Assay Based on the Use of the Thrombin‐Binding Aptamer for the Detection of O6‐Alkylguanine‐DNA Alkyltransferase Activity (Q42137684) (← links)
- Repair of O6-alkylguanines in the nuclear DNA of human lymphocytes and leukaemic cells: analysis at the single-cell level (Q42389408) (← links)
- Debenzylation of O(6)-benzyl-8-oxoguanine in human liver: implications for O(6)-benzylguanine metabolism (Q43552493) (← links)
- How Do DNA Repair Proteins Locate Potential Base Lesions? A Chemical Crosslinking Method to Investigate O6-Alkylguanine-DNA Alkyltransferases (Q44604591) (← links)
- The effects of O6-benzylguanine and hypoxia on the cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea in nitrosourea-resistant SF-763 cells (Q46280203) (← links)
- Sequential administration of temozolomide and fotemustine: depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours. (Q48122815) (← links)
- Comparison between BCNU and procarbazine chemotherapy for treatment of gliomas (Q48326739) (← links)
- Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. (Q48379404) (← links)
- Positive therapeutic interaction between thiopurines and alkylating drugs in human glioma xenografts. (Q55484179) (← links)
- An intronic genetic variation of affects enhancer activity and is associated with glioma susceptibility (Q57490699) (← links)
- The antitumour activity of alkylating agents is not correlated with the levels of glutathione, glutathione transferase and O6-alkylguanine-DNA-alkyltransferase of human tumour xenografts (Q62122185) (← links)
- Increased cytotoxicity of 1-(2-chloroethyl)-1-nitroso-3(4-methyl)-cyclohexylurea by pretreatment with O6-methylguanine in resistant but not in sensitive human melanoma cells (Q69061183) (← links)
- Evidence for Nucleotide Excision Repair as a Modifying Factor ofO6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines (Q73833651) (← links)
- Activation of human O6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone (Q77932320) (← links)